Advances in Bioscience and Biotechnology

Volume 2, Issue 4 (August 2011)

ISSN Print: 2156-8456   ISSN Online: 2156-8502

Google-based Impact Factor: 1.18  Citations  h5-index & Ranking

Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms

HTML  XML Download Download as PDF (Size: 450KB)  PP. 304-310  
DOI: 10.4236/abb.2011.24044    5,314 Downloads   10,290 Views  Citations

Affiliation(s)

.

ABSTRACT

The murine peptidylarginine deiminase (PAD) has five isoforms encoded by different genes and participates in a variety of cellular functions through the citrullination of target proteins. The crystal structure of human PAD4 with a dimeric form was previously solved because of the enzyme’s relevance to rheumatoid arthritis. PAD6, abundant in mouse oocytes and eggs, is believed to take part in early events of embryogenesis, but its biochemical properties are little understood. Here we have purified and characterized a recombinant PAD6. A PAD6 cDNA was cloned from mouse ovary RNA and expressed in Escherichia coli through pET29 and pGEX vectors. When benzoyl-L-arginine ethyl ester was used as a substrate, no appreciable activity was detected with a cell homogenate under conditions where a human PAD4 cDNA caused significant activity. Both proteins were affinity-purified to near homogeneity. The circular dichroism spectra of PAD6 and human PAD4 were similar in the far ultraviolet region. On molecular sieving, PAD6 was eluted faster than human PAD4. The cross-linking of PAD6 with dimethyl suberimidate clearly showed six bands on an sodium dodecyl sulfate-polyacrylamide gel. These results indicate that PAD6 can constitute a hexameric structure. The purified PAD6 still showed no enzymatic activity. This unique structure and loss in enzymatic activity is strongly suggested to favor the formation of egg cytoplasmic sheets as the architectural protein.

Share and Cite:

Taki, H. , Gomi, T. , Knuckley, B. , Thompson, P. , Vugrek, O. , Hirata, K. , Miyahara, T. , Shinoda, K. , Hounoki, H. , Sugiyama, E. , Usui, I. , Urakaze, M. , Tobe, K. , Ishimoto, T. , Inoue, R. , Tanaka, A. , Mano, H. , Ogawa, H. and Mori, H. (2011) Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms. Advances in Bioscience and Biotechnology, 2, 304-310. doi: 10.4236/abb.2011.24044.

Cited by

[1] Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design
2021
[2] Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease
2020
[3] An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes
2019
[4] Mining the human tissue proteome for protein citrullination
2018
[5] Synthesis and biological evaluation of an indazole-based selective protein arginine deiminase 4 (PAD4) inhibitor
ACS Medicinal Chemistry Letters, 2018
[6] Development of Activity-Based Proteomic Probes for Protein Citrullination
Agrobacterium Biology, 2018
[7] Human Deiminases: Isoforms, Substrate Specificities, Kinetics, and Detection
Progress in the Chemistry of Organic Natural Products 106, 2017
[8] Structures and Functions of Peptidylarginine Deiminases
Protein Deimination in Human Health and Disease, 2017
[9] The Use of Genetically Engineered Mice to Study PAD Biology and Pathology
Protein Deimination in Human Health and Disease, 2017
[10] Chemical biology of protein arginine modifications in epigenetic regulation
Chem. Rev, 2015
[11] Protein Arginine Methylation and Citrullination in Epigenetic Regulation
ACS Chemical Biology, 2015
[12] 分子神経科学講座
DSpace at University of Toyama , 2014

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.